What works for human papillomavirus vaccine introduction in low and middle-income countries?
Howard N, Gallagher KE, Mounier-Jack S, Burchett HE, Griffiths UK, Kabakama S, LaMontagne DS, Watson-Jones D.
Papillomavirus Res 2017;4:22-5.
PMID:29179865
PMCID:PMC5710981
Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.
Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Griffiths UK, Feletto M, Burchett HED, LaMontagne DS, Watson-Jones D.
PMID:28575074
PMCID:PMC5456063
Why has global HPV vaccine uptake lagged? A contextual reframing of vaccine introduction.
LaMontagne DS, Gallagher KE, Watson-Jones D.
HPV World 2017; Year 1: 10-12.
Bochner AF, Baeten JM, Rustagi AS, Nakku-Joloba E, Lingappa JR, Mugo NR, Bukusi EA, Kapiga S, Delany-Moretlwe S, Celum C, Barnabas RV; Partners in Prevention HSV/HIV Transmission Study and Partners PrEP Study Teams.
Sex Transm Infect 2017;93:520-9.
PMID:28377421
Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Burchett HED, LaMontagne DS, Watson-Jones D.
Papillomavirus Res 2017;4:72-8.
PMID:29179873
PMCID:PMC5710977
PrayGod G, Changalucha J, Kapiga S, Todd J, Filteau S, Peck R.
J Clin Hypertens (Greenwich). 2017;19:803-6.
PMID:28548437
PMCID:PMC5568948
Wandera B, Tumwesigye NM, Nankabirwa JI, Kambugu AD, Mafigiri DK, Kapiga S, Sethi AK.
PLoS One 2017;12:e0180015.
Ethanol concentration of traditional beverages in Northern Tanzania.
Francis J MD, Grosskurth H, Kapiga S, Weiss H, Mwashiuya J, Changalucha J. 2017;78:476-7.
J Stud Alcohol Drugs.
PMID:28499118
Kapiga S, Harvey S, Muhammad AK, Stöckl H, Mshana G, Hashim R, Hansen C, Lees S, Watts C.
BMC Public Health 2017;17(1):190.
PMID:28193198
PMCID:PMC5307886
PrayGod G, Changalucha J, Kapiga S, Peck R, Todd J, Filteau S.
BMC Infect Dis 2017;17(1):103.
PMID:28137307
PMCID:PMC5282875
